Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Zinc recalled?

Yes — there is an active recall. 47 ongoing FDA recalls mention Zinc (156 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Zinc. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Zinc recalls on record

none so far in 2026; 156 on record, newest first
Class II · Moderate risk

Acure

CGMP Deviations: finished products were manufactured with poor quality water.

Terminated cGMP deviation Diamond Wipes International, Inc. D-0629-2018
Class I · High risk

Limbrel500

Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.

Terminated Unapproved drug Primus Pharmaceuticals, Inc. NDC 68040-606-16 D-0347-2018
Class I · High risk

Limbrel250

Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.

Terminated Unapproved drug Primus Pharmaceuticals, Inc. NDC 68040-605-16 D-0346-2018
Class II · Moderate risk

Vertra Elemental Resistance

CGMP Deviations: products manufactured in a manner that may impact product quality that includes but is not limited to failed viscosity.

Terminated Failed specification Eai-Jr286 INC D-0100-2018
Class II · Moderate risk

VenomX

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 43074-207-01 D-0952-2017
Class II · Moderate risk

StaphWash+Plus+ Skin Protectant

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 43074-101-01 D-0951-2017
Class II · Moderate risk

StingMed Insect bites Skin Protectant. Zinc acetate

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 04307-100-11 D-0950-2017
Class III · Low risk

Zinc Oxide Paste 25%

Labeling: Error on Declared Strength: Error is due to an incorrect value in the Drug Facts Panel. The correct strength is displayed on the primary container.

Terminated Labeling / mix-up Fagron, Inc NDC 51522-0694-5 D-0695-2017
Class II · Moderate risk

MakeSense PHARMA

CGMP Deviations

Terminated cGMP deviation Cherry Hill Sales Co. NDC 69020-205-28 D-0483-2017
Class II · Moderate risk

Zinc Acetate

Does not meet monograph: product exhibits lead levels in excess of the USP monograph limits.

Terminated Unapproved drug Spectrum Laboratory Products, Inc. D-1456-2016